ChromaCode is innovating molecular diagnostics through the use of multiplexing. Multiplexing massively enhances the speed and efficiency with which various molecular diagnostics can be performed. ChromaCode has built their breakthrough High Definition PCR (HDPCRTM) multiplexing platform to use as a diagnostic tool from oncology to noninvasive prenatal testing. The HDPCRTM platform combines novel data science and biochemistry to offer the speed, ease and affordability of real-time quantitative PCR with the dynamic results of next-generation sequencing. Through the use of their devices, ChromaCode can connect patients to the right treatment and ultimately reduce healthcare costs by delivering high quality, low-cost diagnostic tools.

ChromaCode

Founded: 2012
Location: Carlsbad, CA
Employee range: 11 - 50
Funding: $10M C May 2020; $28M C Dec 2019; $12M B May 2017

Short description:

Drug notes:

Long description:

Jobs: